Kentucky Pediatric/Adult Research
Outpatient clinical research site embedded in a rural pediatric practice (Physicians to Children & Adolescents) headquartered in Bardstown, KY. Operating since 1986, the organization has served as an industry-sponsored trial site across Phase I–IV studies with a focus on vaccines and anti-infectives, pediatric populations, and outpatient trial operations. The site provides study coordination, clinical staffing, participant recruitment and enrollment, and regulatory coordination for sponsor-led clinical trials.
Industries
Nr. of Employees
small (1-50)
Kentucky Pediatric/Adult Research
Services
On-site execution of sponsor-led clinical trials including staffing, enrollment, protocol implementation, and data collection.
Design and operational support for pediatric vaccine studies including age-appropriate enrollment and procedures.
Site-level recruitment, screening, and retention practices for outpatient clinical trials.
On-site execution of sponsor-led clinical trials including staffing, enrollment, protocol implementation, and data collection.
Design and operational support for pediatric vaccine studies including age-appropriate enrollment and procedures.
Site-level recruitment, screening, and retention practices for outpatient clinical trials.
Expertise Areas
- Clinical trial management
- Pediatric clinical research
- Vaccine and anti-infective trials
- Participant recruitment and retention
Key Technologies
- Phase I–IV trial methodologies
- Pediatric trial protocols
- Clinical data collection workflows
- Participant recruitment and retention methodologies
News & Updates
Participated in pharmaceutical-sponsored clinical trials since 1986 and conducted approximately 600 Phase I–IV trials.
Selected as one of the first 40 clinical research sites worldwide for an early Phase I–III COVID-19 vaccine trial and conducted associated pediatric enrollment.
Site reported penicillin-resistant pneumococcus in middle ear infections, contributing to subsequent pneumococcal vaccine development efforts.
Participated in pharmaceutical-sponsored clinical trials since 1986 and conducted approximately 600 Phase I–IV trials.
Selected as one of the first 40 clinical research sites worldwide for an early Phase I–III COVID-19 vaccine trial and conducted associated pediatric enrollment.
Site reported penicillin-resistant pneumococcus in middle ear infections, contributing to subsequent pneumococcal vaccine development efforts.